Absence of Clinical Evidence The most critical factor preventing any recommendation or even informed speculation about combining these two compounds is the complete lack of dedicated research
GLP-1 Prescribing + Between-Visit Care in One Product Omada is incorporating GLP-1 prescribing and guided medication care directly into the existing member experience, rather than treating GLP-1s as a standalone care pathway
The first week Your first injection day brings a mix of anticipation and uncertainty
There are no generic launches in Brazil as of today. Management, Torrent Pharmaceuticals | Q4 FY26 Biocon is going direct in Europe selling its own generic liraglutide, an older GLP-1 drug, in the Netherlands rather than through a partner and out-licensing semaglutide to Ajanta Pharma for 26 countries across Africa, the Middle East and Central Asia
Patients may be away from their normal routine, moving between temperatures, passing through airports, or staying in hotels with limited refrigeration options
CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities
